Jan 17, 2006. Recruiting Pierre
Champagne as Consulting Medi-
cal Officer and Jean-Claude Cyr
as Advisory Board member.
Nov 1, 2006. Meeting in Toronto
with VCs and biotech at
BioFinance 2006.
Oct 5, 2006. Presentating at
BioContact
Sept 29, 2006. Provisional U.S.
patent filed for CLE-106 against
sexual dysfunction.
Champagne as Consulting Medi-
cal Officer and Jean-Claude Cyr
as Advisory Board member.
Nov 1, 2006. Meeting in Toronto
with VCs and biotech at
BioFinance 2006.
Oct 5, 2006. Presentating at
BioContact
Sept 29, 2006. Provisional U.S.
patent filed for CLE-106 against
sexual dysfunction.
| Developing Innovative Technologies from Molecule to Treatment |
Next